CHERYL BURRIS: Open Payments
NPI 1225669534 · LAKE OSWEGO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 44 payments from 11 companies in 2025. Trend: 2023 $251 · 2024 $780 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $157 |
| Teva Pharmaceuticals USA, Inc. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Corium, LLC | 7 | $64 |
| Alkermes, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, FANAPT, Auvelity, Azstarys, CAPLYTA, UZEDY, ARISTADA, REXULTI.
Industry payments across OR — which companies pay providers there.
